Ewen Callaway A cell (red) infected with SARS-CoV-2 particles (green).Credit: NIAID/NIH/SPL Researchers developing the Oxford–AstraZeneca COVID-19 vaccine have identified biomarkers that can help to predict whether someone will be protected by the jab they receive. The team at the University of Oxford, UK, identified a ‘correlate of protection from the immune responses of trial participants —...
by Libby Richards, The Conversation Credit: Unsplash/CC0 Public Domain Millions have rolled up their sleeves for the COVID-19 vaccine, but why haven’t they rolled up their pants legs instead? Why do we get most shots in our arms? As an associate professor of nursing with a background in public health, and as a mother of two curious kids, I...
by Ernie Mundell and Robin Foster Sanofi and GlaxoSmithKline announced Monday that their coronavirus vaccine candidate produced powerful responses in a preliminary trial that followed an earlier setback in the vaccine’s development. In selected data that has not yet been published in a peer-reviewed journal, the vaccine “triggered strong immune response amongst adults of all...
by Rik Thompson and Thomas Lloyd, The Conversation Credit: www.shutterstock.com Australian women are being asked to think about the timing of breast cancer screening as they prepare to receive their COVID vaccine. This is in light of US evidence that a normal consequence of COVID vaccination, temporary swelling of the lymph nodes in the armpit, may interfere with how doctors interpret...
By Matthew Herper April 13, 2021 A doctor inoculates someone with AstraZeneca’s Covid-19 vaccine.MICHELE TANTUSSI/GETTY IMAGES Aweek after receiving the AstraZeneca Covid-19 vaccine, a 37-year-old woman in Norway went to the emergency department with fever and persistent headaches. A CAT scan of her head showed a blood clot in blood vessels involved in draining the brain,...
TOPLINE Drugmakers Pfizer and BioNTech asked U.S. regulators on Friday to make their Covid-19 vaccine the first authorized for Americans under the age of 16, after preliminary data suggested the shot is 100% effective at staving off illness in teens ages 12 to 15. KEY FACTS New York City-based Pfizer and Germany’s BioNTech are asking...
BioNTech-Pfizer said Wednesday their vaccine showed 100 percent efficacy against the coronavirus in 12 to 15 year olds, as they eye approval for adolescents to get the jabs before the next school year. Phase 3 trials carried out on 2,260 adolescents in the United States “demonstrated 100 percent efficacy and robust antibody responses”, the companies...
By Stephani Sutherland on April 1, 2021 Credit: Jasmin Merdan Getty Images Last month Robert Duehmig and Bill Griesar—a married couple in their 50s who live in Astoria, Ore., and Portland, Ore.—were each relieved to get their second shot of the Pfizer-BioNTech vaccine for COVID-19. After the jab, Griesar felt nothing more than a sore arm. But for Duehmig, the...
By Denise Grady March 1, 2021, 3:14 p.m. ET Covid-19 vaccinations at the Community Center in Rohnert Park, Calif. Swelling of lymph nodes in the armpit became a recognized side effect in the trials of the Moderna and Pfizer-BioNTech vaccines.Credit…Jim Wilson/The New York Times Coronavirus vaccinations can cause enlarged lymph nodes in the armpit or near the...
By MATTHEW HERPER @matthewherper JANUARY 29, 2021 Reprints MARK RALSTON/AFP VIA GETTY IMAGES Johnson & Johnson said Friday that its single-dose Covid-19 vaccine reduced rates of moderate and severe disease, but the shot appeared less effective in South Africa, where a new coronavirus variant has become common. Overall, the vaccine was 66% effective at preventing moderate to severe disease...
